Literature DB >> 20185692

Amplification loop of the inflammatory process is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migration.

Annabelle Cesaro1, Patrick Brest, Véronique Hofman, Xavier Hébuterne, Scott Wildman, Bernard Ferrua, Sandrine Marchetti, Alain Doglio, Valérie Vouret-Craviari, Franck Galland, Philippe Naquet, Baharia Mograbi, Robert Unwin, Paul Hofman.   

Abstract

Inflammatory bowel diseases (IBD) are characterized during their active phase by polymorphonuclear leukocyte (PMNL) transepithelial migration. The efflux of PMNL into the mucosa is associated with the production of proinflammatory cytokines and the release of ATP from damaged and necrotic cells. The expression and function of purinergic P2X(7) receptor (P2X(7)R) in intestinal epithelial cells (IEC) and its potential role in the "cross talk" between IEC and PMNL have not been explored. The aims of the present study were 1) to examine P2X(7)R expression in IEC (T84 cells) and in human intestinal biopsies; 2) to detect any changes in P2X(7)R expression in T84 cells during PMNL transepithelial migration, and during the active and quiescent phases of IBD; and 3) to test whether P2X(7)R stimulation in T84 monolayers can induce caspase-1 activation and IL-1beta release by IEC. We found that a functional ATP-sensitive P2X(7)R is constitutively expressed at the apical surface of IEC T84 cells. PMNL transmigration regulates dynamically P2X(7)R expression and alters its distribution from the apical to basolateral surface of IEC during the early phase of PMNL transepithelial migration in vitro. P2X(7)R expression was weak in intestinal biopsies obtained during the active phase of IBD. We show that activation of epithelial P2X(7)R is mandatory for PMNL-induced caspase-1 activation and IL-1beta release by IEC. Overall, these changes in P2X(7)R function may serve to tailor the intensity of the inflammatory response and to prevent IL-1beta overproduction and inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20185692     DOI: 10.1152/ajpgi.00282.2009

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  24 in total

Review 1.  Potential for developing purinergic drugs for gastrointestinal diseases.

Authors:  Fernando Ochoa-Cortes; Andromeda Liñán-Rico; Kenneth A Jacobson; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2014-07       Impact factor: 5.325

2.  A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease.

Authors:  Patrick Brest; Pierre Lapaquette; Mouloud Souidi; Kevin Lebrigand; Annabelle Cesaro; Valérie Vouret-Craviari; Bernard Mari; Pascal Barbry; Jean-François Mosnier; Xavier Hébuterne; Annick Harel-Bellan; Baharia Mograbi; Arlette Darfeuille-Michaud; Paul Hofman
Journal:  Nat Genet       Date:  2011-01-30       Impact factor: 38.330

Review 3.  Pathobiology of the neutrophil-intestinal epithelial cell interaction: role in carcinogenesis.

Authors:  Paul-M Hofman
Journal:  World J Gastroenterol       Date:  2010-12-14       Impact factor: 5.742

4.  P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy.

Authors:  Mahmoud G Khalafalla; Lucas T Woods; Jean M Camden; Aslam A Khan; Kirsten H Limesand; Michael J Petris; Laurie Erb; Gary A Weisman
Journal:  J Biol Chem       Date:  2017-08-10       Impact factor: 5.157

Review 5.  The roles of purinergic signaling during gastrointestinal inflammation.

Authors:  Jane A Roberts; Mark K Lukewich; Keith A Sharkey; John B Furness; Gary M Mawe; Alan E Lomax
Journal:  Curr Opin Pharmacol       Date:  2012-10-11       Impact factor: 5.547

6.  The helminth Trichuris suis suppresses TLR4-induced inflammatory responses in human macrophages.

Authors:  M K Ottow; E J Klaver; T C T M van der Pouw Kraan; P D Heijnen; L C Laan; H Kringel; D Y S Vogel; C D Dijkstra; G Kooij; I van Die
Journal:  Genes Immun       Date:  2014-07-10       Impact factor: 2.676

Review 7.  Purinergic signalling in the gastrointestinal tract and related organs in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-12-04       Impact factor: 3.765

8.  Immunolocalization of NLRP3 Inflammasome in Normal Murine Airway Epithelium and Changes following Induction of Ovalbumin-Induced Airway Inflammation.

Authors:  Hai B Tran; Martin D Lewis; Lor Wai Tan; Susan E Lester; Leonie M Baker; Jia Ng; Monica A Hamilton-Bruce; Catherine L Hill; Simon A Koblar; Maureen Rischmueller; Richard E Ruffin; Peter J Wormald; Peter D Zalewski; Carol J Lang
Journal:  J Allergy (Cairo)       Date:  2012-03-18

9.  Subversion of autophagy in adherent invasive Escherichia coli-infected neutrophils induces inflammation and cell death.

Authors:  Abderrahman Chargui; Annabelle Cesaro; Sanda Mimouna; Mohamed Fareh; Patrick Brest; Philippe Naquet; Arlette Darfeuille-Michaud; Xavier Hébuterne; Baharia Mograbi; Valérie Vouret-Craviari; Paul Hofman
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

10.  Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors.

Authors:  Yosuke Kurashima; Takeaki Amiya; Tomonori Nochi; Kumiko Fujisawa; Takeshi Haraguchi; Hideo Iba; Hiroko Tsutsui; Shintaro Sato; Sachiko Nakajima; Hideki Iijima; Masato Kubo; Jun Kunisawa; Hiroshi Kiyono
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.